Involvement of multidrug resistant bacteria in causing community acquired infection is very serious public health issue. The main objective of our study was to determine the prevalence of multidrug resistant bacteria in causing community acquired urinary tract infection. In this study we cultured the 384 mid stream urine samples collected aseptically from the patients attending outpatient department of Seti zonal hospital and having no past history of hospitalization. The organisms isolated were identified by using conventional biochemical tests and antimicrobial susceptibility testing was performed by Kirby Bauer disc diffusion technique. Out of total 384 samples 98 (25.52%) samples showed significant bacterial growth. The most prevalent bacterium isolated was Escherichia coli. 42.86% of the bacteria isolated were found to be multidrug resistant (MDR). The involvement of such large numbers of multidrug resistant bacteria in causing community acquired urinary tract infection is very serious issue and cannot be neglected. And some abrupt initiatives should be taken by the responsible authorities to improve or at least avoid the further worsening of the situation.
ABSRTACTObjectives: This study was aimed to compare the antibacterial activity of peel and juice extracts of citrus fruits.Methods: The antibacterial activity of juice and peel extract of fi ve selected citrus fruits [C1-Citrus reticulata (mandarin orange), C2-Citrus limetta (sweet lime), C3-Citrus aurantifolia (lime), C4-Citrus limon (lemon) and C5-Citrus maxima (pommelo)] on three Gram positive and fi ve Gram negative bacterial strains were examined. The juice and peel extract of citrus fruits was obtained by using absolute ethanol. The obtained extracts were dissolved in 1ml 10% v/v DMSO which was taken to carry out the antibacterial susceptibility assay using agar well diffusion method. Results:The peel extracts of C1 and C2 were found to be more effective against the given Gram-positive bacteria than the juice extracts with maximum zone of inhibition (20.33±1.527) and (15.33±0.577) against Bacillus spp respectively. While the juice extracts of C3 and C4 were more effective against both Gram positive and negative bacteria than their peel extracts with maximum zone of inhibition (26.66±1.15) against S. aureus ATCC 25923 and (20±1) against E. coli ATCC 25922 respectively. The juice extract of C5 was found to be more effective against both Gram positive and negative bacteria than its peel extract with maximum zone of inhibition (18.66±1.154) against E. coli ATCC 25922 except for Bacillus spp in which peel extract showed maximum zone of inhibition i.e. (15±1) Conclusion:This study suggests that these juice and peel extracts may have benefi cial antibacterial roles that can be exploited in controlling unwanted bacterial growth.
Objectives: The main aim of the study was to isolate and identify the bacterial agent and to determine the susceptibility pattern of isolates to different antibiotics.Methods: This retrospective study was conducted from February to October 2015 in microbiology laboratory of All Nepal Hospital Kathmandu, Nepal. The clinical specimens were processed for isolation and identification of bacteria following standard microbiological procedures. Antibiotic susceptibility pattern of isolates were determined according to CLSI guidelines (CLSI 2014)Results: A total of 271 clinical specimens were processed where 164 (60.5%) showed growth positivity. A total 164 bacterial isolates were detected among which 84 (51.22%) were Gram positive 80 (48.78%) were Gram negative bacteria. Thirteen different species of bacteria were isolated. The most prevalent isolate was Staphylococcus aureus 53 (32.30%) followed by E. coli 34 (20.80%), (CoNS) 15 (9.10%), Klebsiella pneumoniae 15 (9.10%), Enterococcus fecalis 12(7.30%), Pseudomonas aeruginosa 10 (6.10%), Acinetobacter spp. 7 (4.30%) Citrobacter spp., Proteus spp., Klebsiella oxytoca were less common. S. aureus was most susceptible to Amikacin. Vancomycin was the most effective drugs for Enterococcus fecalis. Among Gram negative bacteria E. coli was found most sensitive to Polymyxin B (100%) and Imipenem (76.5%) where Pseudomonas aeruginosa was sensitive to, Amikacin, Imipenem (80%). Polymyxin B was the most effective drugs for Klebsiella pneumoniae. Acinetobacter spp. was found highly resistant to different antibiotics.Conclusion: Antibiotic susceptibility evaluation showed Aminoglycosides, Phenicols Polymyxin, and Imipenem was the most effective drugs overall.
Objectives: To determine prevalence of Methicillin Resistant Staphylococcus aureus in different clinical specimens and biofilm production along with antimicrobial susceptibility pattern of isolates. Methods: Cross-sectional study was conducted from September 2019 to February 2020at Sukraraj Tropical and Infectious Disease Hospital. Total 3091 clinical specimens like blood, urine, sputum, pus, swab, body fluid were processed. Identification was done on the basis of colony characteristics, gram staining, culture in Mannitol Salt Agar, coagulase and oxidation fermentation test. Antibiotic susceptibility test and biofilm detection were performed by Kirby Bauer’s disc diffusion methods and Tissue Culture Plate technique (TCP) respectively. Methicillin resistant Staphylococcus species were detected by using Cefoxitin disc. Results: Out of 52 Staphylococcus species, 39 were Staphylococcus aureus and 13 were Coagulase negative Staphylococcus species. Highest numbers of Staphylococcus species were isolated from blood Sixteen (30.8%) were Methicillin resistant Staphylococcus aureus (MRSA) and 5(9.6%) were Methicillin resistant Coagulase negative Staphylococcus species. There was no significant association (p=0.25) between age group and prevalence of MRSA, MSSA, MRCoNS and MSCoNS. Methicillin resistant Staphylococcus species were resistant to antibiotics like amoxicillin, cloxacillin, erythromycin and higher sensitivity was found in gentamycin. Among 52 Staphylococcal isolates, 11(21.1%) were biofilm producers and 41(78.9%) were non biofilm producers. 90.9%of 90.9% of Biofilm producing Staphylococcus species were resistant towards penicillin and erythromycin Conclusion: The study shows Methicillin resistant Staphylococcus species were resistant to most antibiotics and rate of resistance was slightly higher in biofilm producing isolates comparing to other isolates. resistance. Regular surveillance of methicillin resistance Staphylococcus species and routine screening of biofilm production is important.
Protecting surfaces from biofilm formation presents a significant challenge in the biomedical field. The utilization of antimicrobial component-conjugated nanoparticles is becoming an attractive strategy against infectious biofilms. Boron nitride (BN) nanomaterials have a unique biomedical application value due to their excellent biocompatibility. Here, we developed antibioticloaded BN nanoconjugates to combat bacterial biofilms. Antibiofilm testing included two types of pathogens, Staphylococcus aureus and Escherichia coli. Gentamicin was loaded on polydopamine-modified BN nanoparticles (GPBN) to construct a nanoconjugate, which was very effective in killing E. coli and S. aureus planktonic cells. GPBN exhibited equally strong capacity for biofilm destruction, tested on preformed biofilms. A 24 h treatment with the nanoconjugate reduced cell viability by more than 90%. Our results suggest that GPBN adheres to the surface of the biofilm, penetrates inside the biofilm matrix, and finally deactivates the cells. Interestingly, the GPBN coatings also strongly inhibited the formation of bacterial biofilms. Based on these results, we suggest that GPBN could serve as an effective means for treating biofilm-associated infections and as coatings for biofilm prevention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.